| 0 |
VAGINAL FLATULENCE |
106 |
0.3498 |
| 1 |
PRESBYACUSIS |
56 |
0.1818 |
| 2 |
HEART SOUNDS |
15 |
0.1562 |
| 3 |
TOTAL LUNG CAPACITY INCREASED |
30 |
0.1103 |
| 4 |
GENITOURINARY TRACT NEOPLASM |
9 |
0.1084 |
| 5 |
STOMATITIS HAEMORRHAGIC |
11 |
0.0902 |
| 6 |
FEMALE GENITAL TRACT FISTULA |
112 |
0.0655 |
| 7 |
PLEURAL THICKENING |
44 |
0.0643 |
| 8 |
PROLONGED EXPIRATION |
15 |
0.0573 |
| 9 |
PLEURAL FIBROSIS |
58 |
0.0569 |
| 10 |
LARYNGITIS VIRAL |
6 |
0.0566 |
| 11 |
BLOOD MAGNESIUM INCREASED |
48 |
0.0532 |
| 12 |
STOMA SITE ULCER |
9 |
0.0508 |
| 13 |
METASTASES TO SPINAL CORD |
9 |
0.0464 |
| 14 |
ANTICHOLINERGIC SYNDROME |
73 |
0.0458 |
| 15 |
BONE HYPERTROPHY |
7 |
0.0435 |
| 16 |
GASTROINTESTINAL STOMA OUTPUT INCREASED |
20 |
0.0426 |
| 17 |
RADICULOPATHY |
106 |
0.0402 |
| 18 |
PROCTITIS |
112 |
0.0399 |
| 19 |
CHRONIC SINUSITIS |
148 |
0.0394 |
| 20 |
AUTOIMMUNE NEPHRITIS |
7 |
0.0318 |
| 21 |
ARRHYTHMIC STORM |
9 |
0.0269 |
| 22 |
PELVIC NEOPLASM |
9 |
0.0260 |
| 23 |
MACULAR DEGENERATION |
272 |
0.0228 |
| 24 |
BONE CYST |
21 |
0.0224 |
| 25 |
ELECTROCARDIOGRAM QT INTERVAL ABNORMAL |
11 |
0.0219 |
| 26 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
11 |
0.0210 |
| 27 |
TUMOUR PAIN |
27 |
0.0205 |
| 28 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
444 |
0.0205 |
| 29 |
METASTASES TO ABDOMINAL CAVITY |
10 |
0.0203 |
| 30 |
HEMIANOPIA |
20 |
0.0202 |
| 31 |
STICKY SKIN |
8 |
0.0201 |
| 32 |
GASTROENTERITIS RADIATION |
6 |
0.0183 |
| 33 |
DEAFNESS NEUROSENSORY |
58 |
0.0176 |
| 34 |
LUNG DIFFUSION TEST DECREASED |
7 |
0.0175 |
| 35 |
CREATININE RENAL CLEARANCE ABNORMAL |
8 |
0.0173 |
| 36 |
OROPHARYNGEAL SPASM |
7 |
0.0165 |
| 37 |
PEAK EXPIRATORY FLOW RATE DECREASED |
7 |
0.0159 |
| 38 |
EPIGASTRIC DISCOMFORT |
61 |
0.0156 |
| 39 |
ACQUIRED HAEMOPHILIA |
14 |
0.0140 |
| 40 |
SALPINGECTOMY |
8 |
0.0139 |
| 41 |
TORSADE DE POINTES |
109 |
0.0139 |
| 42 |
NECK DEFORMITY |
6 |
0.0135 |
| 43 |
ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL |
6 |
0.0135 |
| 44 |
NIPPLE DISORDER |
8 |
0.0129 |
| 45 |
OSTEOSCLEROSIS |
20 |
0.0127 |
| 46 |
EXPOSURE TO TOXIC AGENT |
36 |
0.0112 |
| 47 |
CHOROIDAL EFFUSION |
9 |
0.0112 |
| 48 |
GASTRIC PH DECREASED |
11 |
0.0107 |
| 49 |
BRUGADA SYNDROME |
11 |
0.0106 |
| 50 |
VAGINAL DISCHARGE |
106 |
0.0105 |
| 51 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
53 |
0.0103 |
| 52 |
PRODUCT INEFFECTIVE |
8 |
0.0102 |
| 53 |
CAMPYLOBACTER GASTROENTERITIS |
6 |
0.0101 |
| 54 |
INTENTIONAL PRODUCT USE ISSUE |
868 |
0.0099 |
| 55 |
GASTROINTESTINAL STOMA COMPLICATION |
15 |
0.0095 |
| 56 |
PARAESTHESIA ORAL |
136 |
0.0094 |
| 57 |
VASCULAR DEVICE INFECTION |
42 |
0.0092 |
| 58 |
FORCED VITAL CAPACITY DECREASED |
6 |
0.0092 |
| 59 |
VANISHING BILE DUCT SYNDROME |
10 |
0.0090 |
| 60 |
OOPHORECTOMY |
8 |
0.0090 |
| 61 |
ORAL CANDIDIASIS |
118 |
0.0090 |
| 62 |
WAIST CIRCUMFERENCE INCREASED |
9 |
0.0087 |
| 63 |
FORCED EXPIRATORY VOLUME DECREASED |
23 |
0.0081 |
| 64 |
GALLBLADDER POLYP |
6 |
0.0076 |
| 65 |
TRAUMATIC HAEMATOMA |
8 |
0.0074 |
| 66 |
NEUTROPHIL COUNT ABNORMAL |
21 |
0.0074 |
| 67 |
DYSBIOSIS |
6 |
0.0073 |
| 68 |
VENTRICULAR TACHYCARDIA |
119 |
0.0072 |
| 69 |
RHEUMATOID FACTOR INCREASED |
8 |
0.0072 |
| 70 |
CONDUCTION DISORDER |
13 |
0.0071 |
| 71 |
IMMUNE-MEDIATED ENTEROCOLITIS |
26 |
0.0071 |
| 72 |
EXPIRED PRODUCT ADMINISTERED |
231 |
0.0069 |
| 73 |
STOMA COMPLICATION |
7 |
0.0069 |
| 74 |
INCORRECT DRUG ADMINISTRATION DURATION |
187 |
0.0066 |
| 75 |
LONG QT SYNDROME |
15 |
0.0063 |
| 76 |
DACTYLITIS |
6 |
0.0061 |
| 77 |
FREQUENT BOWEL MOVEMENTS |
161 |
0.0060 |
| 78 |
DYSPLASIA |
7 |
0.0058 |
| 79 |
ACCIDENTAL POISONING |
8 |
0.0058 |
| 80 |
ANAL HAEMORRHAGE |
16 |
0.0057 |
| 81 |
RECTAL TENESMUS |
7 |
0.0056 |
| 82 |
PYELONEPHRITIS ACUTE |
11 |
0.0056 |
| 83 |
PILOERECTION |
6 |
0.0055 |
| 84 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
25 |
0.0055 |
| 85 |
VENA CAVA THROMBOSIS |
9 |
0.0054 |
| 86 |
RESPIRATION ABNORMAL |
37 |
0.0054 |
| 87 |
SMALL INTESTINAL PERFORATION |
10 |
0.0053 |
| 88 |
CARDIOTOXICITY |
47 |
0.0053 |
| 89 |
CANCER PAIN |
13 |
0.0051 |
| 90 |
PROCEDURAL PAIN |
141 |
0.0051 |
| 91 |
ENTEROCOLITIS |
29 |
0.0050 |
| 92 |
PERIPHERAL MOTOR NEUROPATHY |
7 |
0.0050 |
| 93 |
CYST |
62 |
0.0050 |
| 94 |
ELECTROCARDIOGRAM QT PROLONGED |
177 |
0.0049 |
| 95 |
COLITIS MICROSCOPIC |
23 |
0.0049 |
| 96 |
COLITIS |
184 |
0.0048 |
| 97 |
VENTRICULAR ARRHYTHMIA |
17 |
0.0046 |
| 98 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
18 |
0.0046 |
| 99 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
7 |
0.0046 |
| 100 |
HYPOMANIA |
17 |
0.0046 |
| 101 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
20 |
0.0046 |
| 102 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
12 |
0.0046 |
| 103 |
DEPRESSIVE SYMPTOM |
16 |
0.0045 |
| 104 |
JAUNDICE CHOLESTATIC |
16 |
0.0045 |
| 105 |
APPETITE DISORDER |
30 |
0.0045 |
| 106 |
MUSCULOSKELETAL CHEST PAIN |
70 |
0.0045 |
| 107 |
PEPTIC ULCER |
15 |
0.0045 |
| 108 |
ILEUS PARALYTIC |
20 |
0.0045 |
| 109 |
FOREIGN BODY IN THROAT |
14 |
0.0044 |
| 110 |
SOFT TISSUE INFECTION |
8 |
0.0044 |
| 111 |
COLON CANCER METASTATIC |
7 |
0.0043 |
| 112 |
OSTEOPENIA |
64 |
0.0042 |
| 113 |
RHINITIS ALLERGIC |
18 |
0.0040 |
| 114 |
MENTAL FATIGUE |
6 |
0.0040 |
| 115 |
DRUG EFFECT DELAYED |
18 |
0.0040 |
| 116 |
INTRA-ABDOMINAL FLUID COLLECTION |
7 |
0.0039 |
| 117 |
FAECES DISCOLOURED |
83 |
0.0038 |
| 118 |
MEGACOLON |
6 |
0.0038 |
| 119 |
ABNORMAL FAECES |
31 |
0.0038 |
| 120 |
DECREASED IMMUNE RESPONSIVENESS |
37 |
0.0038 |
| 121 |
PNEUMONIA VIRAL |
12 |
0.0038 |
| 122 |
DERMATITIS EXFOLIATIVE GENERALISED |
13 |
0.0037 |
| 123 |
SMALL INTESTINAL OBSTRUCTION |
46 |
0.0037 |
| 124 |
OSTEOPOROTIC FRACTURE |
7 |
0.0037 |
| 125 |
BLOOD POTASSIUM INCREASED |
59 |
0.0036 |
| 126 |
FAECES HARD |
14 |
0.0036 |
| 127 |
PROCTALGIA |
23 |
0.0036 |
| 128 |
VENTRICULAR FIBRILLATION |
39 |
0.0035 |
| 129 |
FAECALOMA |
19 |
0.0035 |
| 130 |
PULMONARY PAIN |
10 |
0.0034 |
| 131 |
STAPHYLOCOCCUS TEST POSITIVE |
7 |
0.0033 |
| 132 |
GASTROINTESTINAL PAIN |
36 |
0.0033 |
| 133 |
RALES |
19 |
0.0033 |
| 134 |
INTRACRANIAL PRESSURE INCREASED |
18 |
0.0032 |
| 135 |
CHAPPED LIPS |
14 |
0.0032 |
| 136 |
DRUG USE DISORDER |
27 |
0.0032 |
| 137 |
HAEMATOCHEZIA |
177 |
0.0032 |
| 138 |
RECTAL HAEMORRHAGE |
135 |
0.0031 |
| 139 |
PSEUDOMEMBRANOUS COLITIS |
7 |
0.0031 |
| 140 |
PORTAL VEIN THROMBOSIS |
10 |
0.0031 |
| 141 |
URINE OUTPUT INCREASED |
8 |
0.0031 |
| 142 |
CHOLANGITIS |
19 |
0.0031 |
| 143 |
HYPOKALAEMIA |
141 |
0.0031 |
| 144 |
IRON DEFICIENCY ANAEMIA |
28 |
0.0030 |
| 145 |
BOWEL MOVEMENT IRREGULARITY |
23 |
0.0030 |
| 146 |
ARTERIOSPASM CORONARY |
12 |
0.0030 |
| 147 |
DEVICE RELATED SEPSIS |
6 |
0.0030 |
| 148 |
METASTASES TO SPINE |
10 |
0.0030 |
| 149 |
FRUSTRATION TOLERANCE DECREASED |
24 |
0.0030 |
| 150 |
COLORECTAL CANCER METASTATIC |
7 |
0.0030 |
| 151 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
210 |
0.0029 |
| 152 |
LARGE INTESTINAL ULCER |
8 |
0.0029 |
| 153 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
9 |
0.0029 |
| 154 |
FAECES SOFT |
21 |
0.0029 |
| 155 |
HYPOMAGNESAEMIA |
40 |
0.0029 |
| 156 |
COLITIS ULCERATIVE |
128 |
0.0029 |
| 157 |
LUNG ABSCESS |
6 |
0.0029 |
| 158 |
NASAL POLYPS |
14 |
0.0028 |
| 159 |
HYPOPHOSPHATAEMIA |
21 |
0.0028 |
| 160 |
MUCOUS STOOLS |
14 |
0.0028 |
| 161 |
PYODERMA GANGRENOSUM |
10 |
0.0028 |
| 162 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
18 |
0.0028 |
| 163 |
SKIN LESION |
76 |
0.0028 |
| 164 |
SARCOIDOSIS |
13 |
0.0027 |
| 165 |
TUMOUR MARKER INCREASED |
13 |
0.0027 |
| 166 |
THORACIC VERTEBRAL FRACTURE |
8 |
0.0027 |
| 167 |
HYPOALBUMINAEMIA |
21 |
0.0027 |
| 168 |
TOXIC EPIDERMAL NECROLYSIS |
41 |
0.0027 |
| 169 |
ENTERITIS |
17 |
0.0027 |
| 170 |
KERATITIS |
8 |
0.0026 |
| 171 |
GASTROINTESTINAL SOUNDS ABNORMAL |
13 |
0.0026 |
| 172 |
CONSTIPATION |
569 |
0.0026 |
| 173 |
MALNUTRITION |
29 |
0.0026 |
| 174 |
LUNG NEOPLASM |
11 |
0.0026 |
| 175 |
DRUG EFFECT LESS THAN EXPECTED |
38 |
0.0026 |
| 176 |
BLOOD PHOSPHORUS INCREASED |
7 |
0.0026 |
| 177 |
PNEUMONIA ASPIRATION |
64 |
0.0026 |
| 178 |
BLOOD CREATININE DECREASED |
8 |
0.0026 |
| 179 |
OBSTRUCTIVE AIRWAYS DISORDER |
28 |
0.0025 |
| 180 |
OESOPHAGEAL CANDIDIASIS |
10 |
0.0025 |
| 181 |
ILEUS |
31 |
0.0025 |
| 182 |
ONYCHOCLASIS |
17 |
0.0025 |
| 183 |
PNEUMATOSIS INTESTINALIS |
7 |
0.0025 |
| 184 |
LARGE INTESTINE PERFORATION |
17 |
0.0024 |
| 185 |
RESPIRATORY DEPRESSION |
30 |
0.0024 |
| 186 |
ANAL FISSURE |
13 |
0.0024 |
| 187 |
DRUG ABUSE |
201 |
0.0024 |
| 188 |
BLOOD CREATININE INCREASED |
157 |
0.0024 |
| 189 |
NEUTROPHIL COUNT DECREASED |
98 |
0.0024 |
| 190 |
DRUG LEVEL ABOVE THERAPEUTIC |
11 |
0.0024 |
| 191 |
NEPHRITIS |
8 |
0.0024 |
| 192 |
HYPERPARATHYROIDISM SECONDARY |
6 |
0.0024 |
| 193 |
METASTASES TO PERITONEUM |
6 |
0.0024 |
| 194 |
TONGUE DISCOMFORT |
10 |
0.0024 |
| 195 |
FEBRILE BONE MARROW APLASIA |
10 |
0.0024 |
| 196 |
ABDOMINAL INFECTION |
6 |
0.0023 |
| 197 |
ANAL INCONTINENCE |
21 |
0.0023 |
| 198 |
THYROIDITIS |
7 |
0.0023 |
| 199 |
INTENTIONAL PRODUCT MISUSE |
204 |
0.0023 |
| 200 |
LUNG ADENOCARCINOMA |
7 |
0.0023 |
| 201 |
ELECTROLYTE IMBALANCE |
27 |
0.0023 |
| 202 |
LEFT VENTRICULAR FAILURE |
8 |
0.0023 |
| 203 |
APHTHOUS ULCER |
18 |
0.0023 |
| 204 |
BLOOD MAGNESIUM DECREASED |
20 |
0.0023 |
| 205 |
INFUSION RELATED REACTION |
153 |
0.0023 |
| 206 |
EXOSTOSIS |
21 |
0.0023 |
| 207 |
DYSCHEZIA |
7 |
0.0023 |
| 208 |
LUNG OPACITY |
6 |
0.0023 |
| 209 |
PARONYCHIA |
10 |
0.0023 |
| 210 |
CATHETERISATION CARDIAC |
10 |
0.0023 |
| 211 |
DEFORMITY |
21 |
0.0022 |
| 212 |
BRONCHIECTASIS |
15 |
0.0022 |
| 213 |
PERIPHERAL SENSORY NEUROPATHY |
13 |
0.0022 |
| 214 |
BRADYPNOEA |
6 |
0.0022 |
| 215 |
DYSPEPSIA |
218 |
0.0022 |
| 216 |
URINE ABNORMALITY |
10 |
0.0022 |
| 217 |
PNEUMONITIS |
59 |
0.0022 |
| 218 |
PANCREATITIS ACUTE |
47 |
0.0021 |
| 219 |
CLAVICLE FRACTURE |
8 |
0.0021 |
| 220 |
ANAL FISTULA |
11 |
0.0021 |
| 221 |
C-REACTIVE PROTEIN INCREASED |
75 |
0.0021 |
| 222 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
14 |
0.0021 |
| 223 |
DIVERTICULUM INTESTINAL |
9 |
0.0021 |
| 224 |
MELANOCYTIC NAEVUS |
9 |
0.0021 |
| 225 |
FLANK PAIN |
19 |
0.0020 |
| 226 |
DIARRHOEA |
1307 |
0.0020 |
| 227 |
PULMONARY THROMBOSIS |
22 |
0.0020 |
| 228 |
TENDERNESS |
21 |
0.0020 |
| 229 |
UNDERDOSE |
146 |
0.0020 |
| 230 |
BLOOD PRESSURE SYSTOLIC INCREASED |
39 |
0.0020 |
| 231 |
HYPERCAPNIA |
6 |
0.0020 |
| 232 |
DUODENAL ULCER |
14 |
0.0020 |
| 233 |
DERMATITIS ACNEIFORM |
12 |
0.0020 |
| 234 |
HAEMORRHAGIC DIATHESIS |
7 |
0.0020 |
| 235 |
FISTULA |
22 |
0.0020 |
| 236 |
DUODENITIS |
6 |
0.0020 |
| 237 |
PNEUMOTHORAX |
31 |
0.0020 |
| 238 |
RENAL FUNCTION TEST ABNORMAL |
9 |
0.0019 |
| 239 |
METASTASES TO LYMPH NODES |
13 |
0.0019 |
| 240 |
THYROID FUNCTION TEST ABNORMAL |
8 |
0.0019 |
| 241 |
GASTROINTESTINAL PERFORATION |
8 |
0.0019 |
| 242 |
OSTEOARTHRITIS |
81 |
0.0019 |
| 243 |
SENSITIVITY TO WEATHER CHANGE |
10 |
0.0019 |
| 244 |
HYPOVOLAEMIA |
11 |
0.0019 |
| 245 |
LYMPHOEDEMA |
13 |
0.0019 |
| 246 |
ABSCESS LIMB |
8 |
0.0019 |
| 247 |
HUNGER |
26 |
0.0019 |
| 248 |
BLOOD IRON DECREASED |
22 |
0.0019 |
| 249 |
GASTROENTERITIS |
27 |
0.0018 |
| 250 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
41 |
0.0018 |
| 251 |
CARDIAC MURMUR |
16 |
0.0018 |
| 252 |
ANAEMIA |
350 |
0.0018 |
| 253 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
7 |
0.0018 |
| 254 |
STOMATITIS |
111 |
0.0018 |
| 255 |
SCHIZOPHRENIA |
22 |
0.0018 |
| 256 |
ORAL DISCOMFORT |
25 |
0.0018 |
| 257 |
RHINOVIRUS INFECTION |
7 |
0.0018 |
| 258 |
LEFT VENTRICULAR DYSFUNCTION |
12 |
0.0018 |
| 259 |
ELECTROCARDIOGRAM ABNORMAL |
14 |
0.0018 |
| 260 |
DEHYDRATION |
237 |
0.0018 |
| 261 |
SUSPECTED OFF LABEL USE |
8 |
0.0018 |
| 262 |
FLATULENCE |
100 |
0.0018 |
| 263 |
BRONCHOPNEUMONIA |
6 |
0.0018 |
| 264 |
HYPOCALCAEMIA |
33 |
0.0017 |
| 265 |
BUNDLE BRANCH BLOCK RIGHT |
8 |
0.0017 |
| 266 |
BLOOD BILIRUBIN INCREASED |
47 |
0.0017 |
| 267 |
SKIN FISSURES |
34 |
0.0017 |
| 268 |
ABDOMINAL PAIN |
402 |
0.0017 |
| 269 |
PAROSMIA |
13 |
0.0017 |
| 270 |
WHEEZING |
102 |
0.0017 |
| 271 |
C-REACTIVE PROTEIN ABNORMAL |
11 |
0.0017 |
| 272 |
DEFAECATION URGENCY |
12 |
0.0017 |
| 273 |
RIGHT VENTRICULAR FAILURE |
12 |
0.0017 |
| 274 |
DIARRHOEA HAEMORRHAGIC |
16 |
0.0017 |
| 275 |
ERYTHEMA NODOSUM |
6 |
0.0017 |
| 276 |
SELF-MEDICATION |
7 |
0.0017 |
| 277 |
HYPERURICAEMIA |
7 |
0.0017 |
| 278 |
RENAL PAIN |
18 |
0.0017 |
| 279 |
ANORECTAL DISCOMFORT |
9 |
0.0017 |
| 280 |
NEUTROPENIC SEPSIS |
12 |
0.0017 |
| 281 |
PRODUCT RESIDUE PRESENT |
9 |
0.0017 |
| 282 |
HEPATIC FUNCTION ABNORMAL |
62 |
0.0017 |
| 283 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
17 |
0.0017 |
| 284 |
SINUS BRADYCARDIA |
16 |
0.0017 |
| 285 |
AFFECTIVE DISORDER |
13 |
0.0017 |
| 286 |
MONOCYTE COUNT INCREASED |
6 |
0.0017 |
| 287 |
DIZZINESS POSTURAL |
16 |
0.0016 |
| 288 |
OESOPHAGITIS |
18 |
0.0016 |
| 289 |
FEBRILE NEUTROPENIA |
109 |
0.0016 |
| 290 |
INFLAMMATORY BOWEL DISEASE |
16 |
0.0016 |
| 291 |
PNEUMONIA BACTERIAL |
15 |
0.0016 |
| 292 |
MIOSIS |
13 |
0.0016 |
| 293 |
OLIGURIA |
10 |
0.0016 |
| 294 |
ORAL PAIN |
36 |
0.0016 |
| 295 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
289 |
0.0016 |
| 296 |
INTESTINAL OBSTRUCTION |
60 |
0.0016 |
| 297 |
HAEMORRHOIDS |
31 |
0.0016 |
| 298 |
CHOLECYSTITIS ACUTE |
9 |
0.0016 |
| 299 |
ABDOMINAL ABSCESS |
7 |
0.0016 |
| 300 |
DYSPHORIA |
8 |
0.0016 |
| 301 |
DECREASED APPETITE |
364 |
0.0016 |
| 302 |
PRESYNCOPE |
38 |
0.0016 |
| 303 |
CARDIAC ARREST |
129 |
0.0016 |
| 304 |
PERIPHERAL VASCULAR DISORDER |
8 |
0.0016 |
| 305 |
CONTRAINDICATED PRODUCT ADMINISTERED |
47 |
0.0016 |
| 306 |
ASPIRATION |
17 |
0.0016 |
| 307 |
PRODUCT TASTE ABNORMAL |
21 |
0.0015 |
| 308 |
TRISMUS |
8 |
0.0015 |
| 309 |
SKIN WARM |
9 |
0.0015 |
| 310 |
DRY EYE |
77 |
0.0015 |
| 311 |
PERIORBITAL OEDEMA |
8 |
0.0015 |
| 312 |
HEPATITIS ACUTE |
10 |
0.0015 |
| 313 |
ABDOMINAL HERNIA |
7 |
0.0015 |
| 314 |
COMA |
73 |
0.0015 |
| 315 |
ACUTE GRAFT VERSUS HOST DISEASE |
7 |
0.0015 |
| 316 |
PRODUCT ADMINISTRATION INTERRUPTED |
12 |
0.0015 |
| 317 |
TASTE DISORDER |
31 |
0.0015 |
| 318 |
HYPERTHYROIDISM |
22 |
0.0015 |
| 319 |
INTESTINAL PERFORATION |
17 |
0.0015 |
| 320 |
NEPHROGENIC ANAEMIA |
7 |
0.0015 |
| 321 |
ATRIAL FLUTTER |
12 |
0.0015 |
| 322 |
OBSTRUCTION |
6 |
0.0015 |
| 323 |
RENAL IMPAIRMENT |
126 |
0.0015 |
| 324 |
BRAIN INJURY |
15 |
0.0015 |
| 325 |
YELLOW SKIN |
7 |
0.0015 |
| 326 |
GASTROINTESTINAL MOTILITY DISORDER |
8 |
0.0015 |
| 327 |
SENSITIVE SKIN |
11 |
0.0015 |
| 328 |
BLOOD PRESSURE DIASTOLIC DECREASED |
11 |
0.0015 |
| 329 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
37 |
0.0015 |
| 330 |
BREAST CANCER METASTATIC |
16 |
0.0015 |
| 331 |
MYDRIASIS |
19 |
0.0015 |
| 332 |
METASTASES TO LIVER |
26 |
0.0015 |
| 333 |
WEIGHT DECREASED |
412 |
0.0015 |
| 334 |
LOWER RESPIRATORY TRACT INFECTION |
67 |
0.0015 |
| 335 |
FEELING COLD |
41 |
0.0015 |
| 336 |
DECUBITUS ULCER |
12 |
0.0015 |
| 337 |
NON-SMALL CELL LUNG CANCER |
7 |
0.0015 |
| 338 |
HYPONATRAEMIA |
82 |
0.0015 |
| 339 |
INTESTINAL ISCHAEMIA |
8 |
0.0015 |
| 340 |
ENTEROCOCCAL INFECTION |
7 |
0.0014 |
| 341 |
HAEMODYNAMIC INSTABILITY |
11 |
0.0014 |
| 342 |
ACIDOSIS |
11 |
0.0014 |
| 343 |
ABDOMINAL DISTENSION |
150 |
0.0014 |
| 344 |
VITAMIN D DEFICIENCY |
14 |
0.0014 |
| 345 |
INFUSION SITE SWELLING |
9 |
0.0014 |
| 346 |
ASCITES |
42 |
0.0014 |
| 347 |
HYPERVOLAEMIA |
7 |
0.0014 |
| 348 |
PULMONARY TOXICITY |
10 |
0.0014 |
| 349 |
MUCOSAL INFLAMMATION |
37 |
0.0014 |
| 350 |
URINARY RETENTION |
47 |
0.0014 |
| 351 |
HYPERAMMONAEMIA |
7 |
0.0014 |
| 352 |
CARDIOGENIC SHOCK |
20 |
0.0014 |
| 353 |
ERYTHEMA MULTIFORME |
13 |
0.0014 |
| 354 |
MUSCLE STRAIN |
12 |
0.0014 |
| 355 |
METASTASES TO LUNG |
16 |
0.0014 |
| 356 |
ANGINA UNSTABLE |
9 |
0.0014 |
| 357 |
DYSLIPIDAEMIA |
7 |
0.0014 |
| 358 |
DRUG LEVEL DECREASED |
14 |
0.0014 |
| 359 |
CHROMATURIA |
31 |
0.0014 |
| 360 |
POISONING DELIBERATE |
13 |
0.0014 |
| 361 |
PRODUCT PACKAGING ISSUE |
13 |
0.0014 |
| 362 |
SKIN ULCER |
35 |
0.0014 |
| 363 |
GASTROINTESTINAL DISORDER |
121 |
0.0013 |
| 364 |
CYTOMEGALOVIRUS VIRAEMIA |
6 |
0.0013 |
| 365 |
BACTERAEMIA |
16 |
0.0013 |
| 366 |
WHITE BLOOD CELL COUNT DECREASED |
146 |
0.0013 |
| 367 |
HYPOTHYROIDISM |
43 |
0.0013 |
| 368 |
ATELECTASIS |
13 |
0.0013 |
| 369 |
MALABSORPTION |
7 |
0.0013 |
| 370 |
HICCUPS |
11 |
0.0013 |
| 371 |
OVERDOSE |
289 |
0.0013 |
| 372 |
POLYNEUROPATHY |
16 |
0.0013 |
| 373 |
IRON DEFICIENCY |
6 |
0.0013 |
| 374 |
COLITIS ISCHAEMIC |
9 |
0.0013 |
| 375 |
BLOOD CALCIUM DECREASED |
15 |
0.0013 |
| 376 |
PYREXIA |
461 |
0.0013 |
| 377 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
31 |
0.0013 |
| 378 |
BLOOD LACTIC ACID INCREASED |
7 |
0.0013 |
| 379 |
NEUTROPENIA |
179 |
0.0013 |
| 380 |
HAEMOGLOBIN INCREASED |
6 |
0.0013 |
| 381 |
ACCIDENTAL OVERDOSE |
48 |
0.0013 |
| 382 |
IMMUNE THROMBOCYTOPENIA |
6 |
0.0013 |
| 383 |
ANAL ABSCESS |
7 |
0.0013 |
| 384 |
TOXIC SKIN ERUPTION |
13 |
0.0013 |
| 385 |
ISCHAEMIC STROKE |
23 |
0.0013 |
| 386 |
BLOOD TEST ABNORMAL |
18 |
0.0013 |
| 387 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
91 |
0.0013 |
| 388 |
DRUG LEVEL BELOW THERAPEUTIC |
7 |
0.0013 |
| 389 |
DRUG LEVEL INCREASED |
21 |
0.0013 |
| 390 |
GASTRIC ULCER |
24 |
0.0013 |
| 391 |
LIMB DISCOMFORT |
39 |
0.0013 |
| 392 |
URINE OUTPUT DECREASED |
11 |
0.0013 |
| 393 |
BLOOD UREA INCREASED |
21 |
0.0013 |
| 394 |
SPINAL OSTEOARTHRITIS |
11 |
0.0013 |
| 395 |
TUMOUR LYSIS SYNDROME |
11 |
0.0012 |
| 396 |
SLEEP DISORDER |
88 |
0.0012 |
| 397 |
CONJUNCTIVITIS |
23 |
0.0012 |
| 398 |
SKIN TOXICITY |
7 |
0.0012 |
| 399 |
HIATUS HERNIA |
16 |
0.0012 |
| 400 |
DEVICE RELATED INFECTION |
19 |
0.0012 |
| 401 |
PLEURAL EFFUSION |
75 |
0.0012 |
| 402 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
36 |
0.0012 |
| 403 |
HAEMORRHOIDAL HAEMORRHAGE |
6 |
0.0012 |
| 404 |
CLOSTRIDIUM DIFFICILE COLITIS |
13 |
0.0012 |
| 405 |
CHOLELITHIASIS |
40 |
0.0012 |
| 406 |
OROPHARYNGEAL DISCOMFORT |
11 |
0.0012 |
| 407 |
INTENTIONAL OVERDOSE |
78 |
0.0012 |
| 408 |
HEPATOTOXICITY |
27 |
0.0012 |
| 409 |
ORGANISING PNEUMONIA |
6 |
0.0012 |
| 410 |
ABDOMINAL TENDERNESS |
6 |
0.0012 |
| 411 |
LIVER FUNCTION TEST ABNORMAL |
35 |
0.0012 |
| 412 |
FLUID INTAKE REDUCED |
6 |
0.0012 |
| 413 |
SPLENOMEGALY |
14 |
0.0012 |
| 414 |
PRODUCTIVE COUGH |
57 |
0.0012 |
| 415 |
LEUKOPENIA |
59 |
0.0012 |
| 416 |
EPILEPSY |
36 |
0.0012 |
| 417 |
INTERSTITIAL LUNG DISEASE |
57 |
0.0012 |
| 418 |
PLATELET COUNT DECREASED |
125 |
0.0012 |
| 419 |
MALIGNANT NEOPLASM PROGRESSION |
120 |
0.0012 |
| 420 |
PROTHROMBIN TIME PROLONGED |
7 |
0.0012 |
| 421 |
CACHEXIA |
6 |
0.0012 |
| 422 |
SQUAMOUS CELL CARCINOMA OF SKIN |
7 |
0.0012 |
| 423 |
HAIR GROWTH ABNORMAL |
8 |
0.0012 |
| 424 |
PYELONEPHRITIS |
10 |
0.0012 |
| 425 |
WEIGHT FLUCTUATION |
12 |
0.0011 |
| 426 |
ADVERSE REACTION |
15 |
0.0011 |
| 427 |
NYSTAGMUS |
6 |
0.0011 |
| 428 |
SCIATICA |
18 |
0.0011 |
| 429 |
OFF LABEL USE |
987 |
0.0011 |
| 430 |
COMPRESSION FRACTURE |
6 |
0.0011 |
| 431 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
19 |
0.0011 |
| 432 |
RIB FRACTURE |
23 |
0.0011 |
| 433 |
HAEMATOCRIT DECREASED |
22 |
0.0011 |
| 434 |
ALANINE AMINOTRANSFERASE INCREASED |
68 |
0.0011 |
| 435 |
SHOCK HAEMORRHAGIC |
9 |
0.0011 |
| 436 |
PULMONARY ARTERIAL HYPERTENSION |
16 |
0.0011 |
| 437 |
BLOOD POTASSIUM DECREASED |
33 |
0.0011 |
| 438 |
ACUTE CORONARY SYNDROME |
9 |
0.0011 |
| 439 |
TOXICITY TO VARIOUS AGENTS |
183 |
0.0011 |
| 440 |
UROSEPSIS |
10 |
0.0011 |
| 441 |
ANGINA PECTORIS |
31 |
0.0011 |
| 442 |
ASPARTATE AMINOTRANSFERASE INCREASED |
57 |
0.0011 |
| 443 |
ADRENAL INSUFFICIENCY |
13 |
0.0011 |
| 444 |
POLYP |
7 |
0.0011 |
| 445 |
GASTROOESOPHAGEAL REFLUX DISEASE |
86 |
0.0011 |
| 446 |
ASPERGILLUS INFECTION |
7 |
0.0011 |
| 447 |
DISSEMINATED INTRAVASCULAR COAGULATION |
15 |
0.0011 |
| 448 |
PERIORBITAL SWELLING |
6 |
0.0011 |
| 449 |
PEMPHIGOID |
8 |
0.0011 |
| 450 |
DRUG INTERACTION |
168 |
0.0011 |
| 451 |
ARTERIOSCLEROSIS CORONARY ARTERY |
7 |
0.0011 |
| 452 |
TROPONIN INCREASED |
8 |
0.0011 |
| 453 |
CARDIAC FAILURE ACUTE |
7 |
0.0010 |
| 454 |
THROMBOCYTOPENIA |
117 |
0.0010 |
| 455 |
HERPES VIRUS INFECTION |
6 |
0.0010 |
| 456 |
POST PROCEDURAL COMPLICATION |
20 |
0.0010 |
| 457 |
PANCREATITIS |
55 |
0.0010 |
| 458 |
ABDOMINAL PAIN UPPER |
214 |
0.0010 |
| 459 |
UPPER RESPIRATORY TRACT INFECTION |
48 |
0.0010 |
| 460 |
PERICARDIAL EFFUSION |
24 |
0.0010 |
| 461 |
WRONG PRODUCT ADMINISTERED |
7 |
0.0010 |
| 462 |
FEEDING DISORDER |
21 |
0.0010 |
| 463 |
METABOLIC ACIDOSIS |
33 |
0.0010 |
| 464 |
LUNG INFECTION |
16 |
0.0010 |
| 465 |
ACUTE KIDNEY INJURY |
157 |
0.0010 |
| 466 |
HAEMATEMESIS |
26 |
0.0010 |
| 467 |
LUNG INFILTRATION |
9 |
0.0010 |
| 468 |
BLOOD TRIGLYCERIDES INCREASED |
18 |
0.0010 |
| 469 |
LYMPHOCYTE COUNT DECREASED |
18 |
0.0010 |
| 470 |
ENCEPHALOPATHY |
25 |
0.0010 |
| 471 |
BODY TEMPERATURE DECREASED |
10 |
0.0010 |
| 472 |
GLUCOSE TOLERANCE IMPAIRED |
6 |
0.0010 |
| 473 |
DRUG INTOLERANCE |
98 |
0.0010 |
| 474 |
SEPTIC SHOCK |
44 |
0.0010 |
| 475 |
BLOOD SODIUM DECREASED |
19 |
0.0010 |
| 476 |
THIRST |
18 |
0.0010 |
| 477 |
CHOLECYSTITIS |
12 |
0.0010 |
| 478 |
GASTROINTESTINAL INFECTION |
9 |
0.0010 |
| 479 |
DEPRESSED MOOD |
53 |
0.0010 |
| 480 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
10 |
0.0010 |
| 481 |
PAPULE |
7 |
0.0010 |
| 482 |
DRUG INEFFECTIVE |
1308 |
0.0010 |
| 483 |
SYNCOPE |
99 |
0.0010 |
| 484 |
ABDOMINAL PAIN LOWER |
25 |
0.0010 |
| 485 |
SEPSIS |
110 |
0.0010 |
| 486 |
DYSPNOEA EXERTIONAL |
37 |
0.0010 |
| 487 |
INCORRECT DOSE ADMINISTERED |
224 |
0.0010 |
| 488 |
NAUSEA |
776 |
0.0010 |
| 489 |
ALTERED STATE OF CONSCIOUSNESS |
21 |
0.0010 |
| 490 |
PHOTOSENSITIVITY REACTION |
16 |
0.0010 |
| 491 |
DERMATITIS BULLOUS |
7 |
0.0010 |
| 492 |
RHINORRHOEA |
62 |
0.0010 |
| 493 |
BRAIN FOG |
15 |
0.0010 |
| 494 |
DERMATITIS ALLERGIC |
12 |
0.0010 |
| 495 |
INFECTION |
138 |
0.0010 |
| 496 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
52 |
0.0009 |
| 497 |
PROTEINURIA |
18 |
0.0009 |
| 498 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
15 |
0.0009 |
| 499 |
JOINT DISLOCATION |
10 |
0.0009 |
| 500 |
INCREASED APPETITE |
18 |
0.0009 |
| 501 |
SUPRAVENTRICULAR TACHYCARDIA |
9 |
0.0009 |
| 502 |
OROPHARYNGEAL PAIN |
87 |
0.0009 |
| 503 |
LETHARGY |
54 |
0.0009 |
| 504 |
RETCHING |
20 |
0.0009 |
| 505 |
IRRITABLE BOWEL SYNDROME |
20 |
0.0009 |
| 506 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
12 |
0.0009 |
| 507 |
PRESCRIBED OVERDOSE |
18 |
0.0009 |
| 508 |
BRADYCARDIA |
49 |
0.0009 |
| 509 |
DYSURIA |
34 |
0.0009 |
| 510 |
PNEUMONIA |
298 |
0.0009 |
| 511 |
PLATELET COUNT INCREASED |
12 |
0.0009 |
| 512 |
PERITONITIS |
19 |
0.0009 |
| 513 |
CLOSTRIDIUM DIFFICILE INFECTION |
20 |
0.0009 |
| 514 |
NAIL DISORDER |
8 |
0.0009 |
| 515 |
DYSGRAPHIA |
6 |
0.0009 |
| 516 |
RENAL FAILURE CHRONIC |
7 |
0.0009 |
| 517 |
OXYGEN SATURATION DECREASED |
51 |
0.0009 |
| 518 |
PURPURA |
8 |
0.0009 |
| 519 |
LIVER DISORDER |
40 |
0.0009 |
| 520 |
MALAISE |
395 |
0.0009 |
| 521 |
HYPOPHAGIA |
23 |
0.0009 |
| 522 |
RASH MACULO-PAPULAR |
20 |
0.0009 |
| 523 |
CYTOPENIA |
11 |
0.0009 |
| 524 |
POST-TRAUMATIC STRESS DISORDER |
6 |
0.0009 |
| 525 |
NEUROPATHY PERIPHERAL |
85 |
0.0009 |
| 526 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
15 |
0.0009 |
| 527 |
NEPHROPATHY TOXIC |
10 |
0.0009 |
| 528 |
MOBILITY DECREASED |
64 |
0.0009 |
| 529 |
POSTOPERATIVE WOUND INFECTION |
6 |
0.0009 |
| 530 |
ABDOMINAL DISCOMFORT |
149 |
0.0009 |
| 531 |
NEPHROTIC SYNDROME |
6 |
0.0009 |
| 532 |
EAR PAIN |
17 |
0.0009 |
| 533 |
VOMITING |
411 |
0.0009 |
| 534 |
BRAIN OEDEMA |
11 |
0.0009 |
| 535 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
39 |
0.0009 |
| 536 |
RETINAL DETACHMENT |
8 |
0.0009 |
| 537 |
TACHYCARDIA |
77 |
0.0009 |
| 538 |
LARGE INTESTINE POLYP |
6 |
0.0009 |
| 539 |
HYPERTRANSAMINASAEMIA |
6 |
0.0009 |
| 540 |
HEPATIC FAILURE |
26 |
0.0009 |
| 541 |
OEDEMA PERIPHERAL |
105 |
0.0009 |
| 542 |
BACTERIAL INFECTION |
16 |
0.0009 |
| 543 |
INJECTION SITE DISCOMFORT |
9 |
0.0009 |
| 544 |
FULL BLOOD COUNT ABNORMAL |
9 |
0.0009 |
| 545 |
PHOTOPHOBIA |
16 |
0.0008 |
| 546 |
OEDEMA |
46 |
0.0008 |
| 547 |
CYSTITIS |
27 |
0.0008 |
| 548 |
CYTOKINE RELEASE SYNDROME |
17 |
0.0008 |
| 549 |
PAIN IN JAW |
24 |
0.0008 |
| 550 |
ARRHYTHMIA |
40 |
0.0008 |
| 551 |
DIVERTICULUM |
6 |
0.0008 |
| 552 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
44 |
0.0008 |
| 553 |
INTENTIONAL SELF-INJURY |
17 |
0.0008 |
| 554 |
PANCYTOPENIA |
47 |
0.0008 |
| 555 |
TENDONITIS |
13 |
0.0008 |
| 556 |
MYOCLONUS |
10 |
0.0008 |
| 557 |
NIGHT SWEATS |
27 |
0.0008 |
| 558 |
POOR QUALITY SLEEP |
18 |
0.0008 |
| 559 |
FATIGUE |
650 |
0.0008 |
| 560 |
BLOOD PRESSURE FLUCTUATION |
20 |
0.0008 |
| 561 |
SENSATION OF FOREIGN BODY |
7 |
0.0008 |
| 562 |
ERYTHEMA |
170 |
0.0008 |
| 563 |
HYPERKALAEMIA |
29 |
0.0008 |
| 564 |
PRODUCT USE COMPLAINT |
13 |
0.0008 |
| 565 |
HYPERGLYCAEMIA |
30 |
0.0008 |
| 566 |
DISCOMFORT |
50 |
0.0008 |
| 567 |
ORAL DISORDER |
6 |
0.0008 |
| 568 |
HAEMOGLOBIN DECREASED |
84 |
0.0008 |
| 569 |
STEVENS-JOHNSON SYNDROME |
18 |
0.0008 |
| 570 |
URINARY TRACT INFECTION |
138 |
0.0008 |
| 571 |
TREATMENT FAILURE |
67 |
0.0008 |
| 572 |
GENERALISED OEDEMA |
10 |
0.0008 |
| 573 |
MOUTH ULCERATION |
17 |
0.0008 |
| 574 |
HYPOXIA |
28 |
0.0008 |
| 575 |
FULL BLOOD COUNT DECREASED |
16 |
0.0008 |
| 576 |
PERIPHERAL SWELLING |
122 |
0.0008 |
| 577 |
SEIZURE |
91 |
0.0008 |
| 578 |
BONE PAIN |
46 |
0.0008 |
| 579 |
LIPASE INCREASED |
6 |
0.0008 |
| 580 |
SHOCK |
18 |
0.0008 |
| 581 |
INFLUENZA |
87 |
0.0008 |
| 582 |
SOMNOLENCE |
157 |
0.0008 |
| 583 |
RENAL FAILURE ACUTE |
33 |
0.0008 |
| 584 |
MYELOSUPPRESSION |
28 |
0.0008 |
| 585 |
SEASONAL ALLERGY |
11 |
0.0008 |
| 586 |
ANOREXIA |
10 |
0.0008 |
| 587 |
CONFUSIONAL STATE |
125 |
0.0008 |
| 588 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
6 |
0.0008 |
| 589 |
LIP DRY |
7 |
0.0008 |
| 590 |
CHILLS |
90 |
0.0008 |
| 591 |
BLOOD PRESSURE DECREASED |
51 |
0.0008 |
| 592 |
HERPES ZOSTER |
44 |
0.0008 |
| 593 |
NERVOUSNESS |
40 |
0.0008 |
| 594 |
TRANSFUSION |
8 |
0.0008 |
| 595 |
HAEMATURIA |
26 |
0.0008 |
| 596 |
POOR QUALITY PRODUCT ADMINISTERED |
8 |
0.0008 |
| 597 |
SNEEZING |
17 |
0.0008 |
| 598 |
INCONTINENCE |
8 |
0.0008 |
| 599 |
INTERVERTEBRAL DISC DEGENERATION |
7 |
0.0008 |
| 600 |
BLOOD ALBUMIN DECREASED |
6 |
0.0008 |
| 601 |
HYPERLIPIDAEMIA |
9 |
0.0008 |
| 602 |
ABSCESS |
12 |
0.0008 |
| 603 |
HEPATIC ENCEPHALOPATHY |
7 |
0.0007 |
| 604 |
ASTHENIA |
282 |
0.0007 |
| 605 |
APPENDICITIS |
7 |
0.0007 |
| 606 |
QUALITY OF LIFE DECREASED |
10 |
0.0007 |
| 607 |
PRODUCT ADMINISTRATION ERROR |
15 |
0.0007 |
| 608 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
21 |
0.0007 |
| 609 |
LACTIC ACIDOSIS |
24 |
0.0007 |
| 610 |
BONE MARROW FAILURE |
15 |
0.0007 |
| 611 |
POST PROCEDURAL INFECTION |
6 |
0.0007 |
| 612 |
UNRESPONSIVE TO STIMULI |
19 |
0.0007 |
| 613 |
THROAT IRRITATION |
33 |
0.0007 |
| 614 |
MENTAL DISORDER |
32 |
0.0007 |
| 615 |
BODY TEMPERATURE INCREASED |
15 |
0.0007 |
| 616 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
29 |
0.0007 |
| 617 |
MUSCULOSKELETAL STIFFNESS |
64 |
0.0007 |
| 618 |
WHITE BLOOD CELL COUNT INCREASED |
28 |
0.0007 |
| 619 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
35 |
0.0007 |
| 620 |
MELAENA |
16 |
0.0007 |
| 621 |
GENERALISED TONIC-CLONIC SEIZURE |
12 |
0.0007 |
| 622 |
GASTRITIS |
19 |
0.0007 |
| 623 |
DIVERTICULITIS |
20 |
0.0007 |
| 624 |
AGEUSIA |
18 |
0.0007 |
| 625 |
SYNOVITIS |
13 |
0.0007 |
| 626 |
OSTEOMYELITIS |
13 |
0.0007 |
| 627 |
COORDINATION ABNORMAL |
10 |
0.0007 |
| 628 |
DISEASE PROGRESSION |
84 |
0.0007 |
| 629 |
STATUS EPILEPTICUS |
8 |
0.0007 |
| 630 |
LYMPHOPENIA |
10 |
0.0007 |
| 631 |
PAIN OF SKIN |
19 |
0.0007 |
| 632 |
DRUG EFFECT DECREASED |
38 |
0.0007 |
| 633 |
FACIAL PARALYSIS |
6 |
0.0007 |
| 634 |
COUGH |
197 |
0.0007 |
| 635 |
ARTHROPATHY |
39 |
0.0007 |
| 636 |
INFUSION SITE PAIN |
9 |
0.0007 |
| 637 |
CARDIAC FAILURE |
56 |
0.0007 |
| 638 |
IMPAIRED QUALITY OF LIFE |
10 |
0.0007 |
| 639 |
MULTI-ORGAN FAILURE |
12 |
0.0007 |
| 640 |
HYPOTENSION |
139 |
0.0007 |
| 641 |
DELIRIUM |
24 |
0.0007 |
| 642 |
RESPIRATORY TRACT INFECTION |
18 |
0.0007 |
| 643 |
WITHDRAWAL SYNDROME |
29 |
0.0007 |
| 644 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
6 |
0.0007 |
| 645 |
CATARACT |
41 |
0.0007 |
| 646 |
BLOOD CHOLESTEROL INCREASED |
32 |
0.0007 |
| 647 |
APATHY |
10 |
0.0007 |
| 648 |
ANHEDONIA |
18 |
0.0007 |
| 649 |
HYPERTENSION |
145 |
0.0007 |
| 650 |
DYSPHONIA |
40 |
0.0007 |
| 651 |
EAR DISCOMFORT |
7 |
0.0007 |
| 652 |
POOR VENOUS ACCESS |
7 |
0.0007 |
| 653 |
GENERAL PHYSICAL HEALTH DETERIORATION |
78 |
0.0007 |
| 654 |
VENTRICULAR EXTRASYSTOLES |
7 |
0.0007 |
| 655 |
HERNIA |
13 |
0.0007 |
| 656 |
GALLBLADDER DISORDER |
12 |
0.0007 |
| 657 |
POLLAKIURIA |
28 |
0.0007 |
| 658 |
COLON CANCER |
10 |
0.0007 |
| 659 |
MUSCLE SPASMS |
123 |
0.0007 |
| 660 |
DRUG-INDUCED LIVER INJURY |
21 |
0.0007 |
| 661 |
SINUS CONGESTION |
9 |
0.0007 |
| 662 |
RENAL DISORDER |
31 |
0.0007 |
| 663 |
HEART RATE IRREGULAR |
15 |
0.0007 |
| 664 |
TOOTHACHE |
12 |
0.0007 |
| 665 |
SUDDEN DEATH |
7 |
0.0007 |
| 666 |
ECONOMIC PROBLEM |
10 |
0.0007 |
| 667 |
DISORIENTATION |
26 |
0.0007 |
| 668 |
DYSPHAGIA |
62 |
0.0007 |
| 669 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
6 |
0.0007 |
| 670 |
CANDIDA INFECTION |
11 |
0.0007 |
| 671 |
CARDIOMEGALY |
8 |
0.0006 |
| 672 |
GRAND MAL CONVULSION |
6 |
0.0006 |
| 673 |
DECREASED ACTIVITY |
7 |
0.0006 |
| 674 |
NASAL CONGESTION |
38 |
0.0006 |
| 675 |
AGRANULOCYTOSIS |
12 |
0.0006 |
| 676 |
HEPATIC ENZYME INCREASED |
44 |
0.0006 |
| 677 |
THINKING ABNORMAL |
12 |
0.0006 |
| 678 |
EJECTION FRACTION DECREASED |
10 |
0.0006 |
| 679 |
HAIR COLOUR CHANGES |
8 |
0.0006 |
| 680 |
PULMONARY EMBOLISM |
61 |
0.0006 |
| 681 |
THERAPY PARTIAL RESPONDER |
10 |
0.0006 |
| 682 |
DEVICE OCCLUSION |
9 |
0.0006 |
| 683 |
DYSPNOEA |
362 |
0.0006 |
| 684 |
COVID-19 |
112 |
0.0006 |
| 685 |
HEART RATE INCREASED |
63 |
0.0006 |
| 686 |
HYPOAESTHESIA |
95 |
0.0006 |
| 687 |
ANAPHYLACTIC REACTION |
35 |
0.0006 |
| 688 |
MUSCLE ATROPHY |
8 |
0.0006 |
| 689 |
RED BLOOD CELL COUNT DECREASED |
18 |
0.0006 |
| 690 |
NERVE INJURY |
7 |
0.0006 |
| 691 |
RASH MACULAR |
22 |
0.0006 |
| 692 |
EPISTAXIS |
47 |
0.0006 |
| 693 |
HEPATITIS |
16 |
0.0006 |
| 694 |
PULMONARY OEDEMA |
28 |
0.0006 |
| 695 |
HEADACHE |
392 |
0.0006 |
| 696 |
CONTUSION |
60 |
0.0006 |
| 697 |
JOINT SWELLING |
75 |
0.0006 |
| 698 |
INFLAMMATION |
32 |
0.0006 |
| 699 |
PAIN |
380 |
0.0006 |
| 700 |
HOSPITALISATION |
95 |
0.0006 |
| 701 |
FIBROMYALGIA |
15 |
0.0006 |
| 702 |
PLASMA CELL MYELOMA |
24 |
0.0006 |
| 703 |
GOUT |
11 |
0.0006 |
| 704 |
MENTAL STATUS CHANGES |
17 |
0.0006 |
| 705 |
SPEECH DISORDER |
32 |
0.0006 |
| 706 |
HOT FLUSH |
46 |
0.0006 |
| 707 |
JOINT INJURY |
13 |
0.0006 |
| 708 |
DRY SKIN |
81 |
0.0006 |
| 709 |
BLISTER |
34 |
0.0006 |
| 710 |
IMMUNODEFICIENCY |
9 |
0.0006 |
| 711 |
CYTOMEGALOVIRUS INFECTION |
10 |
0.0006 |
| 712 |
PRESCRIBED UNDERDOSE |
12 |
0.0006 |
| 713 |
PAIN IN EXTREMITY |
177 |
0.0006 |
| 714 |
RHABDOMYOLYSIS |
25 |
0.0006 |
| 715 |
HYPOAESTHESIA ORAL |
9 |
0.0006 |
| 716 |
JOINT RANGE OF MOTION DECREASED |
8 |
0.0006 |
| 717 |
JAUNDICE |
16 |
0.0006 |
| 718 |
VERTIGO |
36 |
0.0006 |
| 719 |
HEPATIC STEATOSIS |
11 |
0.0006 |
| 720 |
HEMIPARESIS |
10 |
0.0006 |
| 721 |
BALANCE DISORDER |
51 |
0.0006 |
| 722 |
ATAXIA |
7 |
0.0006 |
| 723 |
MOTOR DYSFUNCTION |
6 |
0.0006 |
| 724 |
CIRCULATORY COLLAPSE |
10 |
0.0006 |
| 725 |
EUPHORIC MOOD |
6 |
0.0006 |
| 726 |
ARTHRALGIA |
242 |
0.0006 |
| 727 |
BACK PAIN |
135 |
0.0006 |
| 728 |
MUSCULOSKELETAL DISCOMFORT |
10 |
0.0006 |
| 729 |
IMPAIRED HEALING |
19 |
0.0006 |
| 730 |
NOCTURIA |
7 |
0.0006 |
| 731 |
PULMONARY HYPERTENSION |
12 |
0.0006 |
| 732 |
NEOPLASM PROGRESSION |
20 |
0.0006 |
| 733 |
PETECHIAE |
6 |
0.0006 |
| 734 |
FOLLICULITIS |
6 |
0.0006 |
| 735 |
GLAUCOMA |
11 |
0.0006 |
| 736 |
GLOMERULAR FILTRATION RATE DECREASED |
7 |
0.0006 |
| 737 |
HEART RATE DECREASED |
20 |
0.0006 |
| 738 |
DRUG ERUPTION |
10 |
0.0006 |
| 739 |
CHOKING |
11 |
0.0006 |
| 740 |
EATING DISORDER |
12 |
0.0006 |
| 741 |
INSOMNIA |
150 |
0.0006 |
| 742 |
ARTHRITIS |
44 |
0.0006 |
| 743 |
HYPERSOMNIA |
16 |
0.0006 |
| 744 |
POISONING |
7 |
0.0006 |
| 745 |
CHEST PAIN |
103 |
0.0006 |
| 746 |
CELLULITIS |
28 |
0.0006 |
| 747 |
LOSS OF CONSCIOUSNESS |
71 |
0.0006 |
| 748 |
GAIT DISTURBANCE |
106 |
0.0006 |
| 749 |
NASOPHARYNGITIS |
102 |
0.0006 |
| 750 |
DYSGEUSIA |
41 |
0.0006 |
| 751 |
PRODUCT PRESCRIBING ISSUE |
12 |
0.0006 |
| 752 |
RESTLESS LEGS SYNDROME |
10 |
0.0005 |
| 753 |
HYPERSENSITIVITY |
102 |
0.0005 |
| 754 |
METASTASES TO BONE |
9 |
0.0005 |
| 755 |
CHEST DISCOMFORT |
56 |
0.0005 |
| 756 |
ATRIAL FIBRILLATION |
53 |
0.0005 |
| 757 |
RESPIRATORY DISTRESS |
15 |
0.0005 |
| 758 |
PSYCHOTIC DISORDER |
16 |
0.0005 |
| 759 |
URINARY INCONTINENCE |
16 |
0.0005 |
| 760 |
TRANSAMINASES INCREASED |
12 |
0.0005 |
| 761 |
TOOTH DISORDER |
12 |
0.0005 |
| 762 |
DEEP VEIN THROMBOSIS |
35 |
0.0005 |
| 763 |
GLOSSODYNIA |
12 |
0.0005 |
| 764 |
RASH PRURITIC |
29 |
0.0005 |
| 765 |
HEPATIC CIRRHOSIS |
10 |
0.0005 |
| 766 |
FALL |
177 |
0.0005 |
| 767 |
PULMONARY CONGESTION |
7 |
0.0005 |
| 768 |
LUNG DISORDER |
26 |
0.0005 |
| 769 |
PRODUCT DOSE OMISSION IN ERROR |
15 |
0.0005 |
| 770 |
CONDITION AGGRAVATED |
161 |
0.0005 |
| 771 |
CORONARY ARTERY DISEASE |
16 |
0.0005 |
| 772 |
SUICIDE ATTEMPT |
32 |
0.0005 |
| 773 |
RENAL FAILURE |
70 |
0.0005 |
| 774 |
DERMATITIS CONTACT |
6 |
0.0005 |
| 775 |
EAR INFECTION |
14 |
0.0005 |
| 776 |
INSURANCE ISSUE |
8 |
0.0005 |
| 777 |
NEOPLASM |
6 |
0.0005 |
| 778 |
ALOPECIA |
102 |
0.0005 |
| 779 |
OSTEONECROSIS |
17 |
0.0005 |
| 780 |
ORTHOSTATIC HYPOTENSION |
9 |
0.0005 |
| 781 |
POST PROCEDURAL HAEMORRHAGE |
6 |
0.0005 |
| 782 |
TACHYPNOEA |
7 |
0.0005 |
| 783 |
PALLOR |
14 |
0.0005 |
| 784 |
DIZZINESS |
256 |
0.0005 |
| 785 |
LIVER FUNCTION TEST INCREASED |
11 |
0.0005 |
| 786 |
SWOLLEN TONGUE |
16 |
0.0005 |
| 787 |
OSTEOPOROSIS |
21 |
0.0005 |
| 788 |
CORONARY ARTERY OCCLUSION |
7 |
0.0005 |
| 789 |
KIDNEY INFECTION |
10 |
0.0005 |
| 790 |
ACUTE MYOCARDIAL INFARCTION |
15 |
0.0005 |
| 791 |
COVID-19 PNEUMONIA |
6 |
0.0005 |
| 792 |
DRY MOUTH |
41 |
0.0005 |
| 793 |
ASTHMA |
57 |
0.0005 |
| 794 |
PRODUCT PRESCRIBING ERROR |
12 |
0.0005 |
| 795 |
ULCER |
8 |
0.0005 |
| 796 |
NEPHROLITHIASIS |
23 |
0.0005 |
| 797 |
MYALGIA |
85 |
0.0005 |
| 798 |
CARPAL TUNNEL SYNDROME |
7 |
0.0005 |
| 799 |
IRRITABILITY |
30 |
0.0005 |
| 800 |
BLOOD PRESSURE INCREASED |
76 |
0.0005 |
| 801 |
RHEUMATOID ARTHRITIS |
56 |
0.0005 |
| 802 |
RESTLESSNESS |
18 |
0.0005 |
| 803 |
GASTROINTESTINAL HAEMORRHAGE |
41 |
0.0005 |
| 804 |
LIVER INJURY |
12 |
0.0005 |
| 805 |
INJECTION SITE EXTRAVASATION |
6 |
0.0005 |
| 806 |
HYPERCALCAEMIA |
6 |
0.0005 |
| 807 |
MUSCULAR WEAKNESS |
55 |
0.0005 |
| 808 |
SWELLING |
45 |
0.0005 |
| 809 |
DYSSTASIA |
14 |
0.0005 |
| 810 |
WEIGHT INCREASED |
107 |
0.0005 |
| 811 |
PARAESTHESIA |
75 |
0.0005 |
| 812 |
FACE OEDEMA |
8 |
0.0005 |
| 813 |
TRANSIENT ISCHAEMIC ATTACK |
16 |
0.0005 |
| 814 |
SKIN EXFOLIATION |
40 |
0.0005 |
| 815 |
CARDIOMYOPATHY |
7 |
0.0005 |
| 816 |
BRONCHITIS |
35 |
0.0005 |
| 817 |
RESPIRATORY ARREST |
13 |
0.0005 |
| 818 |
PULMONARY MASS |
7 |
0.0005 |
| 819 |
MOVEMENT DISORDER |
15 |
0.0005 |
| 820 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
8 |
0.0005 |
| 821 |
SKIN CANCER |
10 |
0.0005 |
| 822 |
HALLUCINATION |
35 |
0.0005 |
| 823 |
PRODUCT USE IN UNAPPROVED INDICATION |
115 |
0.0005 |
| 824 |
HAEMATOMA |
12 |
0.0005 |
| 825 |
DIPLOPIA |
12 |
0.0005 |
| 826 |
VISUAL IMPAIRMENT |
57 |
0.0005 |
| 827 |
NEUROTOXICITY |
8 |
0.0005 |
| 828 |
EOSINOPHILIA |
8 |
0.0005 |
| 829 |
RASH |
199 |
0.0005 |
| 830 |
PRODUCT DOSE OMISSION ISSUE |
134 |
0.0005 |
| 831 |
ROAD TRAFFIC ACCIDENT |
19 |
0.0005 |
| 832 |
COLD SWEAT |
8 |
0.0005 |
| 833 |
MENTAL IMPAIRMENT |
11 |
0.0005 |
| 834 |
PALPITATIONS |
53 |
0.0005 |
| 835 |
DIABETES MELLITUS INADEQUATE CONTROL |
8 |
0.0005 |
| 836 |
EYE HAEMORRHAGE |
6 |
0.0004 |
| 837 |
MALIGNANT MELANOMA |
6 |
0.0004 |
| 838 |
NECK PAIN |
25 |
0.0004 |
| 839 |
LIMB INJURY |
12 |
0.0004 |
| 840 |
PANIC ATTACK |
16 |
0.0004 |
| 841 |
TREATMENT NONCOMPLIANCE |
24 |
0.0004 |
| 842 |
SENSORY DISTURBANCE |
7 |
0.0004 |
| 843 |
URTICARIA |
73 |
0.0004 |
| 844 |
TREMOR |
72 |
0.0004 |
| 845 |
BLOOD GLUCOSE ABNORMAL |
8 |
0.0004 |
| 846 |
CARDIO-RESPIRATORY ARREST |
18 |
0.0004 |
| 847 |
DERMATITIS |
9 |
0.0004 |
| 848 |
MEMORY IMPAIRMENT |
59 |
0.0004 |
| 849 |
DYSARTHRIA |
16 |
0.0004 |
| 850 |
THERAPY NON-RESPONDER |
19 |
0.0004 |
| 851 |
AGITATION |
31 |
0.0004 |
| 852 |
BLOOD URINE PRESENT |
8 |
0.0004 |
| 853 |
LIP SWELLING |
14 |
0.0004 |
| 854 |
SKIN DISORDER |
14 |
0.0004 |
| 855 |
SLEEP APNOEA SYNDROME |
8 |
0.0004 |
| 856 |
RASH ERYTHEMATOUS |
20 |
0.0004 |
| 857 |
ACUTE RESPIRATORY FAILURE |
8 |
0.0004 |
| 858 |
DRUG EFFECT INCOMPLETE |
15 |
0.0004 |
| 859 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
83 |
0.0004 |
| 860 |
ANXIETY |
116 |
0.0004 |
| 861 |
RESPIRATORY FAILURE |
29 |
0.0004 |
| 862 |
APHASIA |
12 |
0.0004 |
| 863 |
LACRIMATION INCREASED |
12 |
0.0004 |
| 864 |
PRODUCT PHYSICAL ISSUE |
8 |
0.0004 |
| 865 |
SKIN DISCOLOURATION |
18 |
0.0004 |
| 866 |
CEREBRAL HAEMORRHAGE |
14 |
0.0004 |
| 867 |
LUNG NEOPLASM MALIGNANT |
16 |
0.0004 |
| 868 |
EMOTIONAL DISORDER |
12 |
0.0004 |
| 869 |
ILLNESS |
40 |
0.0004 |
| 870 |
VISION BLURRED |
53 |
0.0004 |
| 871 |
TOOTH LOSS |
8 |
0.0004 |
| 872 |
BASAL CELL CARCINOMA |
6 |
0.0004 |
| 873 |
ANGER |
13 |
0.0004 |
| 874 |
END STAGE RENAL DISEASE |
7 |
0.0004 |
| 875 |
DEAFNESS |
10 |
0.0004 |
| 876 |
CHRONIC KIDNEY DISEASE |
29 |
0.0004 |
| 877 |
CYANOSIS |
6 |
0.0004 |
| 878 |
HEAD INJURY |
12 |
0.0004 |
| 879 |
FEELING HOT |
23 |
0.0004 |
| 880 |
FLUID RETENTION |
19 |
0.0004 |
| 881 |
HYPOGLYCAEMIA |
18 |
0.0004 |
| 882 |
INJURY |
26 |
0.0004 |
| 883 |
CEREBRAL INFARCTION |
9 |
0.0004 |
| 884 |
ADVERSE DRUG REACTION |
33 |
0.0004 |
| 885 |
LYMPHADENOPATHY |
13 |
0.0004 |
| 886 |
FEELING ABNORMAL |
88 |
0.0004 |
| 887 |
INTERVERTEBRAL DISC PROTRUSION |
8 |
0.0004 |
| 888 |
HYPERHIDROSIS |
47 |
0.0004 |
| 889 |
CHOLESTASIS |
7 |
0.0004 |
| 890 |
INFLUENZA LIKE ILLNESS |
30 |
0.0004 |
| 891 |
ERUCTATION |
7 |
0.0004 |
| 892 |
WOUND |
10 |
0.0004 |
| 893 |
CARDIOVASCULAR DISORDER |
9 |
0.0004 |
| 894 |
SWELLING FACE |
23 |
0.0004 |
| 895 |
INTERNATIONAL NORMALISED RATIO INCREASED |
10 |
0.0004 |
| 896 |
SPINAL FRACTURE |
7 |
0.0003 |
| 897 |
ANAPHYLACTIC SHOCK |
9 |
0.0003 |
| 898 |
CEREBROVASCULAR ACCIDENT |
59 |
0.0003 |
| 899 |
PRODUCT USE ISSUE |
65 |
0.0003 |
| 900 |
ECZEMA |
18 |
0.0003 |
| 901 |
MYOCARDIAL INFARCTION |
60 |
0.0003 |
| 902 |
LABORATORY TEST ABNORMAL |
10 |
0.0003 |
| 903 |
GASTROENTERITIS VIRAL |
6 |
0.0003 |
| 904 |
LEUKOCYTOSIS |
6 |
0.0003 |
| 905 |
VIRAL INFECTION |
11 |
0.0003 |
| 906 |
DEPRESSION |
75 |
0.0003 |
| 907 |
NEURALGIA |
8 |
0.0003 |
| 908 |
BURNING SENSATION |
23 |
0.0003 |
| 909 |
PRURITUS |
125 |
0.0003 |
| 910 |
OSTEONECROSIS OF JAW |
8 |
0.0003 |
| 911 |
THROMBOSIS |
26 |
0.0003 |
| 912 |
HAEMOPTYSIS |
9 |
0.0003 |
| 913 |
DYSKINESIA |
13 |
0.0003 |
| 914 |
FOOT FRACTURE |
6 |
0.0003 |
| 915 |
ADVERSE EVENT |
29 |
0.0003 |
| 916 |
PULMONARY FIBROSIS |
6 |
0.0003 |
| 917 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
9 |
0.0003 |
| 918 |
JOINT STIFFNESS |
8 |
0.0003 |
| 919 |
ABNORMAL BEHAVIOUR |
12 |
0.0003 |
| 920 |
CARDIAC DISORDER |
28 |
0.0003 |
| 921 |
TYPE 2 DIABETES MELLITUS |
10 |
0.0003 |
| 922 |
DRUG WITHDRAWAL SYNDROME |
26 |
0.0003 |
| 923 |
THROAT TIGHTNESS |
8 |
0.0003 |
| 924 |
FLUSHING |
30 |
0.0003 |
| 925 |
MIGRAINE |
28 |
0.0003 |
| 926 |
NO ADVERSE EVENT |
53 |
0.0003 |
| 927 |
BONE DENSITY DECREASED |
9 |
0.0003 |
| 928 |
DEMENTIA |
8 |
0.0003 |
| 929 |
ABASIA |
7 |
0.0003 |
| 930 |
MOOD SWINGS |
9 |
0.0003 |
| 931 |
DEATH |
242 |
0.0003 |
| 932 |
DISTURBANCE IN ATTENTION |
15 |
0.0003 |
| 933 |
AMNESIA |
18 |
0.0003 |
| 934 |
SINUSITIS |
28 |
0.0003 |
| 935 |
STAPHYLOCOCCAL INFECTION |
9 |
0.0003 |
| 936 |
RENAL INJURY |
8 |
0.0003 |
| 937 |
RESPIRATORY DISORDER |
8 |
0.0003 |
| 938 |
DIABETES MELLITUS |
20 |
0.0003 |
| 939 |
AGGRESSION |
13 |
0.0003 |
| 940 |
COGNITIVE DISORDER |
12 |
0.0003 |
| 941 |
SURGERY |
15 |
0.0003 |
| 942 |
NEOPLASM MALIGNANT |
17 |
0.0003 |
| 943 |
COMPLETED SUICIDE |
21 |
0.0003 |
| 944 |
MEDICATION ERROR |
14 |
0.0003 |
| 945 |
ABORTION SPONTANEOUS |
10 |
0.0002 |
| 946 |
HIP FRACTURE |
8 |
0.0002 |
| 947 |
ANGIOEDEMA |
11 |
0.0002 |
| 948 |
MUSCULOSKELETAL PAIN |
13 |
0.0002 |
| 949 |
INTENTIONAL DOSE OMISSION |
7 |
0.0002 |
| 950 |
EYE SWELLING |
9 |
0.0002 |
| 951 |
TINNITUS |
11 |
0.0002 |
| 952 |
GAIT INABILITY |
8 |
0.0002 |
| 953 |
EYE PRURITUS |
8 |
0.0002 |
| 954 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
6 |
0.0002 |
| 955 |
CARDIAC FAILURE CONGESTIVE |
19 |
0.0002 |
| 956 |
FEMUR FRACTURE |
7 |
0.0002 |
| 957 |
THERAPY INTERRUPTED |
16 |
0.0002 |
| 958 |
EXTRA DOSE ADMINISTERED |
9 |
0.0002 |
| 959 |
HAEMORRHAGE |
23 |
0.0002 |
| 960 |
ACNE |
16 |
0.0002 |
| 961 |
OCULAR HYPERAEMIA |
10 |
0.0002 |
| 962 |
THERAPEUTIC RESPONSE UNEXPECTED |
9 |
0.0002 |
| 963 |
EMOTIONAL DISTRESS |
24 |
0.0002 |
| 964 |
SKIN IRRITATION |
9 |
0.0002 |
| 965 |
BLOOD GLUCOSE INCREASED |
37 |
0.0002 |
| 966 |
EXPOSURE DURING PREGNANCY |
12 |
0.0002 |
| 967 |
FUNGAL INFECTION |
6 |
0.0002 |
| 968 |
CONVULSION |
10 |
0.0002 |
| 969 |
DRUG DEPENDENCE |
28 |
0.0002 |
| 970 |
CRYING |
6 |
0.0002 |
| 971 |
PSORIASIS |
21 |
0.0002 |
| 972 |
EYE PAIN |
9 |
0.0002 |
| 973 |
UNEVALUABLE EVENT |
12 |
0.0002 |
| 974 |
SUICIDAL IDEATION |
14 |
0.0002 |
| 975 |
PRODUCT STORAGE ERROR |
13 |
0.0001 |
| 976 |
MULTIPLE SCLEROSIS |
7 |
0.0001 |
| 977 |
BLOOD GLUCOSE DECREASED |
7 |
0.0001 |
| 978 |
THERAPEUTIC RESPONSE DECREASED |
8 |
0.0001 |
| 979 |
DEPENDENCE |
7 |
0.0001 |
| 980 |
ACCIDENTAL EXPOSURE TO PRODUCT |
13 |
0.0001 |
| 981 |
DISEASE RECURRENCE |
6 |
0.0001 |
| 982 |
INJECTION SITE PAIN |
37 |
0.0001 |
| 983 |
MULTIPLE SCLEROSIS RELAPSE |
8 |
0.0001 |
| 984 |
INJECTION SITE BRUISING |
9 |
0.0001 |
| 985 |
MATERNAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 986 |
PROSTATE CANCER |
9 |
0.0001 |
| 987 |
DEVICE ISSUE |
10 |
0.0001 |
| 988 |
INJECTION SITE PRURITUS |
7 |
0.0001 |
| 989 |
INJECTION SITE SWELLING |
8 |
0.0001 |
| 990 |
EYE IRRITATION |
6 |
0.0001 |
| 991 |
PRODUCT SUBSTITUTION ISSUE |
6 |
0.0001 |
| 992 |
INJECTION SITE REACTION |
7 |
0.0001 |
| 993 |
INJECTION SITE ERYTHEMA |
12 |
0.0001 |
| 994 |
BREAST CANCER |
8 |
0.0001 |